New Era of Oral Anticoagulation for Japanese Non-Valvular Atrial Fibrillation Patients

被引：1
|
作者：
Hirano, Teruyuki [1 ]
机构：
[1] Oita Univ, Fac Med, Dept Neurol, Hasama, Yufu 8795593, Japan
来源：
CIRCULATION JOURNAL | 2014年 / 78卷 / 06期
关键词：
INTRACEREBRAL HEMORRHAGE; WARFARIN; DABIGATRAN;
D O I：
10.1253/circj.CJ-14-0454
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1317 / 1319
页数：3
相关论文
共 50 条
  • [41] Novel oral anticoagulants in non-valvular atrial fibrillation
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 115 - 129
  • [42] Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
    Marieke G. M. Weernink
    Melissa C. W. Vaanholt
    Catharina G. M. Groothuis-Oudshoorn
    Clemens von Birgelen
    Maarten J. IJzerman
    Janine A. van Til
    American Journal of Cardiovascular Drugs, 2018, 18 : 493 - 502
  • [43] Patients' Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
    Weernink, Marieke G. M.
    Vaanholt, Melissa C. W.
    Groothuis-Oudshoorn, Catharina G. M.
    von Birgelen, Clemens
    IJzerman, Maarten J.
    van Til, Janine A.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 493 - 502
  • [44] Era of new anticoagulants in the treatment of non-valvular atrial fibrillation: prospects and challenges
    Safiullina, Z. M.
    Shalaev, S. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (02) : 171 - 176
  • [45] Racial differences and geographic variations in oral anticoagulation treatment among Medicare patients with non-valvular atrial fibrillation
    Jackson, Larry R.
    Kang, Amiee
    Noxon, Virginia
    Atreja, Nipun
    Hines, Dionne M.
    Hagan, Melissa
    Jiang, Jenny
    Atwater, Brett D.
    PLOS ONE, 2024, 19 (12):
  • [46] Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution
    Manaka Tagaya
    Daiji Yoshikawa
    Yoshinori Sugishita
    Fumi Yamauchi
    Takehiro Ito
    Tomohito Kamada
    Masataka Yoshinaga
    Daisuke Mukaide
    Wakaya Fujiwara
    Hiroatsu Yokoi
    Mutsuharu Hayashi
    Eiichi Watanabe
    Junichi Ishii
    Yukio Ozaki
    Hideo Izawa
    Heart and Vessels, 2016, 31 : 957 - 962
  • [47] Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution
    Tagaya, Manaka
    Yoshikawa, Daiji
    Sugishita, Yoshinori
    Yamauchi, Fumi
    Ito, Takehiro
    Kamada, Tomohito
    Yoshinaga, Masataka
    Mukaide, Daisuke
    Fujiwara, Wakaya
    Yokoi, Hiroatsu
    Hayashi, Mutsuharu
    Watanabe, Eiichi
    Ishii, Junichi
    Ozaki, Yukio
    Izawa, Hideo
    HEART AND VESSELS, 2016, 31 (06) : 957 - 962
  • [48] COST EFFECTIVENESS OF ORAL ANTICOAGULATION THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION PATIENTS: WARFARIN VERSUS THE NEW ORAL ANTICOAGULANTS RIVAROXABAN, DABIGATRAN AND APIXABAN
    Ortiz-Cartagena, Ismael
    Gotay, Antonio Orraca
    Acevedo, Jose
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 490 - 490
  • [49] Anticoagulation in patients with non-valvular atrial fibrillation (nvAF) and chronic kidney disease (CKD)
    Zeymer, Uwe
    Bonnemeier, Hendrik
    Wanner, Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (23) : 1642 - 1649
  • [50] Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?
    Wong, C. W.
    HONG KONG MEDICAL JOURNAL, 2016, 22 (06) : 608 - 615
12345